Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.
Department of Medical Genetics, The Children's Memorial Heath Institute, 04-730 Warsaw, Poland.
Int J Mol Sci. 2020 Jun 26;21(12):4564. doi: 10.3390/ijms21124564.
Mucolipidosis type IV (MLIV) is an ultra-rare lysosomal storage disorder caused by biallelic mutations in gene encoding the transient receptor potential channel mucolipin-1. So far, 35 pathogenic or likely pathogenic MLIV-related variants have been described. Clinical manifestations include severe intellectual disability, speech deficit, progressive visual impairment leading to blindness, and myopathy. The severity of the condition may vary, including less severe psychomotor delay and/or ocular findings. As no striking recognizable facial dysmorphism, skeletal anomalies, organomegaly, or lysosomal enzyme abnormalities in serum are common features of MLIV, the clinical diagnosis may be significantly improved because of characteristic ophthalmological anomalies. This review aims to outline the pathophysiology and genetic defects of this condition with a focus on the genotype-phenotype correlation amongst cases published in the literature. The authors will present their own clinical observations and long-term outcomes in adult MLIV cases.
黏脂贮积症 IV 型(MLIV)是一种由编码瞬时受体电位通道黏脂素-1 的基因双等位基因突变引起的超罕见溶酶体贮积症。迄今为止,已有 35 种致病性或可能致病性的 MLIV 相关变异体被描述。临床表现包括严重智力残疾、言语缺陷、进行性视力损害导致失明和肌病。病情的严重程度可能有所不同,包括较轻的精神运动发育迟缓和/或眼部表现。由于 MLIV 常见的特征是没有明显可识别的面部畸形、骨骼异常、器官肿大或血清溶酶体酶异常,因此,由于特征性的眼科异常,临床诊断可能会得到显著改善。本综述旨在概述该疾病的病理生理学和遗传缺陷,并重点关注文献中报道的病例中的基因型-表型相关性。作者将介绍他们自己在成年 MLIV 病例中的临床观察和长期结果。